Utah Trial Innovation Center
Mission: Optimize efficiency and quality through operational hypotheses and value-driven methods
Vision: Accelerating the translation of research to the bedside
The Utah Trial Innovation Center, or Utah TIC, was funded by the NIH National Center for Advancing Translational Science (NCATS) in July 2016 as part of the larger Trial Innovation Network. The seven-year, $28 million grant was awarded to Dr. J. Michael Dean, MD, MBA, professor and vice chairman for research in the Department of Pediatrics and Associate Dean for Clinical Research within the School of Medicine. The Utah TIC has helped provide financial support for key University of Utah clinical research stakeholders and infrastructure, including the Data Coordinating Center, the Institutional Review Board (IRB), the Office of Sponsored Projects, the Clinical Trials Office, and the Center for Clinical and Translational Science (CCTS). To support clinical study teams and the work of executing large multicenter trials, the Utah TIC has assembled an extraordinary team of project managers, clinical data managers, business analysts, biostatisticians, informaticists, and experts in information technology, contracting and regulatory work.
J. Michael Dean, MD, MBA
Associate Dean for Clinical Research
Director, Clinical Trials Office
Chief, Division of Pediatric Critical Care Medicine
Vice Chairman for Research, Department of Pediatrics
University of Utah School of Medicine
All efforts at the Utah TIC are overseen by PI Dr. Dean. Management of the day to day activities, operations, and staff is provided by Executive Director Jeri Burr. The Utah TIC is organized into six areas.
Innovative workflows, tools, and improved study designs developed at the Utah Trial Innovation Center are improving clinical trial science for future research and playing an integral role in accelerating the translation of important research to the bedside.